Mckesson corporation
MCK AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock holds a moderate value rating. If you have positions, consider retaining; for new ones, wait for a value score above 4.
MCK Current Performance
-1.15%
Mckesson corporation
1.66%
Avg of Sector
-0.54%
S&P500
Top 10 High Relevance to MCK
| Symbol | Value | Trend | Swing Trading | Whale Interest | Dividend | Market Cap | Add to Watchlist |
|---|---|---|---|---|---|---|---|
COR Cencora inc | 4 | 5 | 4 | 4 | 4 | 41B | |
CVS Cvs health corp | 3 | 1 | 2 | 3 | 5 | 88.1B | |
REYN Reynolds consumer products inc | 5 | 3 | 4 | 1 | 2 | 5.6B | |
SPTN Spartannash co | 4 | 4 | 3 | 3 | 5 | 781.1M | |
ENR Energizer holdings inc | 5 | 2 | 2 | 3 | 5 | 2.2B |
- COR Cencora incValue 4Trend 5Swing Trading 4Whale Interest 4Dividend 4Market Cap 41BSee more
MCK Profile
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.